Loading investment round...

Round announcement
biopharmadive.com
Enveda Harvests Another 150m Advance Nature Inspired Drugs
fiercebiotech.com
Enveda Closes 130m Series C Funding To Deliver Multiple Clinical Readouts From A Pipeline Of 10 Development Candidates
biospace.com
Coverage
https://www.sales Ttols.ai/enveda-biosciences-raises-130m-series-c/
Mixed
A mixed round, some signals are off the norm.
Round size vs peers
Larger than the typical Series C round (2.6×).
Syndicate size
Party round (10 investors), diffuse ownership and signal.
Insider conviction
All-new money, no prior investors re-upped.
Investor track record
Mostly newer or unproven managers.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.